Logo image of ZEST.MI

ZEST (ZEST.MI) Stock Fundamental Analysis

BIT:ZEST - Euronext Milan - IT0005013013 - Common Stock - Currency: EUR

0.166  0 (-0.9%)

Fundamental Rating

3

Overall ZEST gets a fundamental rating of 3 out of 10. We evaluated ZEST against 107 industry peers in the Capital Markets industry. Both the profitability and financial health of ZEST have multiple concerns. While showing a medium growth rate, ZEST is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ZEST was profitable.
ZEST had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ZEST reported negative net income in multiple years.
In the past 5 years ZEST reported 4 times negative operating cash flow.
ZEST.MI Yearly Net Income VS EBIT VS OCF VS FCFZEST.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

With an excellent Return On Assets value of 11.72%, ZEST belongs to the best of the industry, outperforming 93.46% of the companies in the same industry.
ZEST's Return On Equity of 15.40% is fine compared to the rest of the industry. ZEST outperforms 77.57% of its industry peers.
Industry RankSector Rank
ROA 11.72%
ROE 15.4%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZEST.MI Yearly ROA, ROE, ROICZEST.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

With an excellent Profit Margin value of 92.08%, ZEST belongs to the best of the industry, outperforming 96.26% of the companies in the same industry.
ZEST's Profit Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 42.58%, ZEST is in line with its industry, outperforming 59.81% of the companies in the same industry.
In the last couple of years the Gross Margin of ZEST has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 92.08%
GM 42.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y41.09%
PM growth 5Y50.3%
GM growth 3Y-18.5%
GM growth 5Y-9.45%
ZEST.MI Yearly Profit, Operating, Gross MarginsZEST.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

2

2. Health

2.1 Basic Checks

There is no outstanding debt for ZEST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ZEST.MI Yearly Shares OutstandingZEST.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
ZEST.MI Yearly Total Debt VS Total AssetsZEST.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 0.98, we must say that ZEST is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.98, ZEST is in line with its industry, outperforming 48.60% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that ZEST is not too dependend on debt financing.
The Debt to Equity ratio of ZEST (0.07) is better than 79.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 0.98
ROIC/WACCN/A
WACCN/A
ZEST.MI Yearly LT Debt VS Equity VS FCFZEST.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

ZEST has a Current Ratio of 0.70. This is a bad value and indicates that ZEST is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ZEST (0.70) is comparable to the rest of the industry.
A Quick Ratio of 0.70 indicates that ZEST may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.70, ZEST is in line with its industry, outperforming 50.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.7
ZEST.MI Yearly Current Assets VS Current LiabilitesZEST.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M

More info and screens

5

3. Growth

3.1 Past

ZEST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 213.72%, which is quite impressive.
ZEST shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 38.26% yearly.
ZEST shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.41%.
The Revenue has been growing by 14.68% on average over the past years. This is quite good.
EPS 1Y (TTM)213.72%
EPS 3Y16.84%
EPS 5Y38.26%
EPS Q2Q%98.05%
Revenue 1Y (TTM)-16.41%
Revenue growth 3Y16.57%
Revenue growth 5Y14.68%
Sales Q2Q%-25.22%

3.2 Future

The Earnings Per Share is expected to decrease by -57.79% on average over the next years. This is quite bad
ZEST is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.81% yearly.
EPS Next Y-116.54%
EPS Next 2Y-43.01%
EPS Next 3Y-57.79%
EPS Next 5YN/A
Revenue Next Year18.28%
Revenue Next 2Y13.59%
Revenue Next 3Y11.81%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ZEST.MI Yearly Revenue VS EstimatesZEST.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
ZEST.MI Yearly EPS VS EstimatesZEST.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.02 0.04 0.06

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 2.37, the valuation of ZEST can be described as very cheap.
100.00% of the companies in the same industry are more expensive than ZEST, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.50. ZEST is valued rather cheaply when compared to this.
The Forward Price/Earnings Ratio is negative for ZEST. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 2.37
Fwd PE N/A
ZEST.MI Price Earnings VS Forward Price EarningsZEST.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZEST.MI Per share dataZEST.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

A cheap valuation may be justified as ZEST's earnings are expected to decrease with -57.79% in the coming years.
PEG (NY)N/A
PEG (5Y)0.06
EPS Next 2Y-43.01%
EPS Next 3Y-57.79%

More info and screens

0

5. Dividend

5.1 Amount

ZEST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZEST

BIT:ZEST (7/16/2025, 7:00:00 PM)

0.166

0 (-0.9%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.46%
Inst Owner ChangeN/A
Ins Owners8.56%
Ins Owner ChangeN/A
Market Cap26.68M
Analysts85.71
Price Target0.52 (213.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.51%
Valuation
Industry RankSector Rank
PE 2.37
Fwd PE N/A
P/S 3.2
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 0.55
EV/EBITDA N/A
EPS(TTM)0.07
EY42.17%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.05
BVpS0.31
TBVpS0.3
PEG (NY)N/A
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 11.72%
ROE 15.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 92.08%
GM 42.58%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y41.09%
PM growth 5Y50.3%
GM growth 3Y-18.5%
GM growth 5Y-9.45%
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.71%
Cap/Sales 0.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.7
Quick Ratio 0.7
Altman-Z 0.98
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.27%
Cap/Sales(5y)1.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)213.72%
EPS 3Y16.84%
EPS 5Y38.26%
EPS Q2Q%98.05%
EPS Next Y-116.54%
EPS Next 2Y-43.01%
EPS Next 3Y-57.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.41%
Revenue growth 3Y16.57%
Revenue growth 5Y14.68%
Sales Q2Q%-25.22%
Revenue Next Year18.28%
Revenue Next 2Y13.59%
Revenue Next 3Y11.81%
Revenue Next 5YN/A
EBIT growth 1Y-119.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-100%
EBIT Next 3Y-52.78%
EBIT Next 5YN/A
FCF growth 1Y-28033.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4636.69%
OCF growth 3YN/A
OCF growth 5YN/A